GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Vimian Group AB (OSTO:VIMIAN) » Definitions » Net Income From Continuing Operations

Vimian Group AB (OSTO:VIMIAN) Net Income From Continuing Operations : kr445 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Vimian Group AB Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Vimian Group AB's net income from continuing operations for the three months ended in Sep. 2024 was kr115 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Sep. 2024 was kr445 Mil.

Vimian Group AB Net Income From Continuing Operations Historical Data

The historical data trend for Vimian Group AB's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vimian Group AB Net Income From Continuing Operations Chart

Vimian Group AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income From Continuing Operations
Get a 7-Day Free Trial -5.59 60.05 221.82 432.72 461.66

Vimian Group AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 117.26 30.19 151.27 149.28 114.55

Vimian Group AB Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr445 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vimian Group AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Vimian Group AB (OSTO:VIMIAN) » Definitions » Net Income From Continuing Operations
Comparable Companies
OSTO:DVYSR OSTO:SENZA NGM:LUMITO OSTO:IMMNOV OSTO:AROC OSTO:PROGEN XSAT:GEAN NGM:LEVBIO XSAT:SPERM NGM:ATANA TMO DHR XSWX:LONN A IQV IDXX MTD WAT SHSE:603259 ILMN
Traded in Other Exchanges
VIMGF:USA 0V0:Germany
Address
Riddargatan 19, Stockholm, SWE, SE-11457
Website
https://www.vimian.com
Vimian Group AB specializes in the areas of animal health such as specialty pharma, diagnostics, medtech, and veterinary services. It offers proprietary diagnostics, prescription and non-prescription treatments for preventive care, and treatment of chronic conditions for companion animals, with a strong position within allergy, dermatology, otology, and specialized nutrition. Its geographical segments include Europe, North America, and the Rest of the world.

Vimian Group AB Headlines

No Headlines